Referred to the Subcommittee on Health.
This resolution expresses the sense of Congress that more research, funding, and public awareness are needed for the neurological disorder dystonia. It urges the Director of the National Institutes of Health to take a leadership role, encourages specific NIH institutes to support research and education, and calls for better diagnostics, epidemiological study, and patient access to therapies. It does not create law, authorize spending, or force agencies to act; it is an official statement of congressional priorities and recommendations.
National Institutes of Health (NIH)
Concurrent resolutions are adopted by both the House and the Senate but are not presented to the President and do not have the force of law; they express Congress's views or direct internal congressional actions. This text was introduced in the House and referred to committee as part of the legislative process.
This concurrent resolution expresses the sense of Congress that the NIH should lead expanded study of dystonia.
It urges continued inter-institute collaboration, increased NIH funding for basic research, improved diagnostics and epidemiology, better patient access to therapies, and greater public and professional education partnerships.
Nonbinding, narrow, low‑cost research/awareness resolution fits patterns of frequently adopted concurrent resolutions; few substantive objections expected.
Relative to its intended legislative type, this bill functions as a non‑binding expression urging federal research agencies to prioritize dystonia research and related activities; it clearly frames the problem and names responsible agencies but leaves implementation, funding, and accountability to subsequent action.
Left emphasizes patient access and research funding expansion
These are examples from the analysis, not a ranked list of the most-affected groups.
Left emphasizes patient access and research funding expansion
Supportive: views the resolution as a needed federal response to a under-recognized neurological disorder.
Sees research, access, and education priorities as consistent with health equity and disability support goals.
Cautious support: welcomes attention to a neglected disorder but wants clarity on costs, measurable goals, and avoidance of duplicative programs.
Prefers targeted, accountable federal action.
Mixed to skeptical: supports medical research and helping patients but is wary of calls for increased federal spending and expanded NIH priorities without fiscal constraints.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Nonbinding, narrow, low‑cost research/awareness resolution fits patterns of frequently adopted concurrent resolutions; few substantive objections expected.
The bill has not accumulated any surfaced votes yet.
Left emphasizes patient access and research funding expansion
Nonbinding, narrow, low‑cost research/awareness resolution fits patterns of frequently adopted concurrent resolutions; few substantive obje…
Relative to its intended legislative type, this bill functions as a non‑binding expression urging federal research agencies to prioritize dystonia research and related activities; it clearly frames the problem and names…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.